Mycophenolate mofetil Recruiting Phase 1 Trials for Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / ISS Stage II Plasma Cell Myeloma / Recurrent Small Lymphocytic Lymphoma / Refractory Small Lymphocytic Lymphoma / Myelodysplastic Syndrome / Acute Lymphoblastic Leukaemia Recurrent / Leukemias / chronic, recurrent Lymphocytic Leukemia / Acute myeloid leukaemia (in remission) / Therapy-Related Myelodysplastic Syndrome / Refractory Hodgkin Lymphoma / Chronic Lymphocytic Leukaemia (CLL) / DS Stage II Plasma Cell Myeloma / Recurrent Non-Hodgkin Lymphoma / acute, recurrent Myeloid Leukemia / Acute Lymphoblastic Leukemia in Remission / refractory Non-Hodgkin's lymphoma / High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements / Chronic Lymphocytic Leukemia (CLL) - Refractory / DS Stage III Plasma Cell Myeloma / Recurrent Hodgkin Lymphoma / ISS Stage III Plasma Cell Myeloma / Secondary Acute Myeloid Leukemia (Secondary AML, sAML) / Acute Biphenotypic Leukemia (ABL) / Therapy-Related Acute Myeloid Leukemia / Refractory Acute Lymphoblastic Leukemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01619761NK Cells in Cord Blood Transplantation